476 related articles for article (PubMed ID: 31203722)
1. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease.
Soontararak S; Chow L; Johnson V; Coy J; Webb C; Wennogle S; Dow S
PLoS One; 2019; 14(8):e0220522. PubMed ID: 31369623
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease.
Lin R; Chen H; Shu W; Sun M; Fang L; Shi Y; Pang Z; Wu W; Liu Z
J Transl Med; 2018 Dec; 16(1):359. PubMed ID: 30558634
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease.
Masu Y; Kanazawa Y; Kakuta Y; Shimoyama Y; Onodera M; Naito T; Moroi R; Kuroha M; Kimura T; Shiga H; Kinouchi Y; Masamune A
Sci Rep; 2021 Aug; 11(1):16672. PubMed ID: 34404881
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
Frehn L; Jansen A; Bennek E; Mandic AD; Temizel I; Tischendorf S; Verdier J; Tacke F; Streetz K; Trautwein C; Sellge G
PLoS One; 2014; 9(9):e106750. PubMed ID: 25215528
[TBL] [Abstract][Full Text] [Related]
6. Patients With Inflammatory Bowel Disease Show IgG Immune Responses Towards Specific Intestinal Bacterial Genera.
Bourgonje AR; Roo-Brand G; Lisotto P; Sadaghian Sadabad M; Reitsema RD; de Goffau MC; Faber KN; Dijkstra G; Harmsen HJM
Front Immunol; 2022; 13():842911. PubMed ID: 35693832
[TBL] [Abstract][Full Text] [Related]
7. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease.
Shapiro JM; de Zoete MR; Palm NW; Laenen Y; Bright R; Mallette M; Bu K; Bielecka AA; Xu F; Hurtado-Lorenzo A; Shah SA; Cho JH; LeLeiko NS; Sands BE; Flavell RA; Clemente JC
Cell Host Microbe; 2021 Jan; 29(1):83-93.e3. PubMed ID: 33385335
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
[TBL] [Abstract][Full Text] [Related]
11. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
Cook L; Wong MQ; Rees WD; Schick A; Lisko DJ; Lunken GR; Wang X; Peters H; Oliveira L; Lau T; Mah R; Bressler B; Levings MK; Steiner TS
Inflamm Bowel Dis; 2024 May; 30(5):820-828. PubMed ID: 37874904
[TBL] [Abstract][Full Text] [Related]
14. Specificities of the fecal microbiota in inflammatory bowel disease.
Sokol H; Seksik P; Rigottier-Gois L; Lay C; Lepage P; Podglajen I; Marteau P; Doré J
Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease.
Palm NW; de Zoete MR; Cullen TW; Barry NA; Stefanowski J; Hao L; Degnan PH; Hu J; Peter I; Zhang W; Ruggiero E; Cho JH; Goodman AL; Flavell RA
Cell; 2014 Aug; 158(5):1000-1010. PubMed ID: 25171403
[TBL] [Abstract][Full Text] [Related]
16. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer.
Lavelle A; Nancey S; Reimund JM; Laharie D; Marteau P; Treton X; Allez M; Roblin X; Malamut G; Oeuvray C; Rolhion N; Dray X; Rainteau D; Lamaziere A; Gauliard E; Kirchgesner J; Beaugerie L; Seksik P; Peyrin-Biroulet L; Sokol H
Gut Microbes; 2022; 14(1):2078620. PubMed ID: 35638103
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin recognition of fecal bacteria in stunted and non-stunted children: findings from the Afribiota study.
Huus KE; Rodriguez-Pozo A; Kapel N; Nestoret A; Habib A; Dede M; Manges A; Collard JM; Sansonetti PJ; Vonaesch P; Finlay BB;
Microbiome; 2020 Jul; 8(1):113. PubMed ID: 32718353
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
[TBL] [Abstract][Full Text] [Related]
20. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]